July 2026 Research Update

Together, these papers reinforce that Marfan syndrome can involve ongoing risk across the aorta and sometimes other arteries, even after earlier events or procedures. Results also point to meaningful differences by sex, and to possible future tools that might help track risk more precisely, although those tools are still early-stage. [1] [2] [3] [4] [5]

In a Polish cohort of 151 people followed for a median 6.8 years, more than half experienced at least one thoracic aortic event, with the first event typically around age 33 and including both planned surgeries and dissections. Event-free survival was shorter in men and in people with higher systemic scores, mainly before age 35, while a certain type of FBN1 gene change (haploinsufficiency) was linked to later events. [1]

The same cohort also showed that repeat thoracic aortic events happened: 18 people had a second event, and this was more common after a dissection than after an elective (planned) operation. Mitral valve surgery occurred in 13% of patients, reflecting that monitoring often includes both the aorta and heart valves. [1]

In a larger U.S. cohort of 783 adults, men had a higher burden of aneurysms (including outside the chest) and higher rates of atrial and ventricular rhythm problems, while women more often had mitral valve prolapse. The proportion of people with a history of dissection was similar in men and women, and the differences in aneurysm burden and rhythm problems persisted in the subgroup with a confirmed genetic result. [2]

Two case reports highlight that risk is not limited to the aortic root. One report described a man with heritable thoracic aortic disease (including one Marfan patient) who developed a type B dissection years after a personalized external aortic root support (PEARS) procedure and needed additional complex aortic surgery, underscoring that distal (downstream) aorta problems can still occur after root-focused procedures. [5]

Another single-patient report described a 32-year-old man with previously unrecognized Marfan syndrome who had a vertebral artery dissection leading to a posterior circulation stroke, with a small opening between heart chambers judged unlikely to be the main cause. This illustrates that in some people with Marfan features, artery dissections can involve vessels beyond the aorta, although this is one case and may not represent typical risk. [4]

One exploratory computer-simulation study in a single Marfan patient with chronic type B dissection suggested that certain blood-flow and vessel-wall force patterns along the descending aorta tracked with aorta size and the amount of false-channel space after dissection. This was not a clinical outcomes study, but it points to possible future noninvasive markers for surveillance research. [3]

For patients and caregivers, this group of studies mainly adds context about what has been observed in real-world Marfan populations: aortic events can occur relatively early in adulthood for some people, repeat events can happen after a first event, and patterns can differ between men and women (including rhythm problems and aneurysms outside the main chest aorta). Rare case reports remind readers that dissections can sometimes involve other arteries or more distant parts of the aorta, but single cases cannot predict an individual persons risk. The simulation work is background research that may help refine monitoring tools in the future, but it is not yet evidence that changes current care. [1] [2] [3] [4] [5]

One hospital-based study focused on the uncommon but severe situation of type A aortic dissection during pregnancy or shortly after delivery. It suggests that the same emergency event can occur in different risk groups, and that in women with hypertension the aortic root size at the time of dissection may be smaller than in women with Marfan syndrome. [6]

In 42 pregnant or puerperal patients treated surgically from 2010 to 2026, overall maternal deaths were 4 out of 42. The median aortic root diameter at dissection was smaller in the hypertension group (38.5 mm) than in the Marfan group (51.5 mm) and the group with other or unidentified high-risk factors (50.5 mm). [6]

Timing also mattered in this dataset: neonatal survival was 100% when dissection began in the third trimester (26 out of 26), while fetal loss was common when onset was in the second trimester (6 out of 9). Live birth rates and maternal mortality did not show statistically clear differences between the three risk-factor groups in this report. [6]

This evidence is most relevant as context for people thinking about or experiencing pregnancy while living with Marfan syndrome or other aortic risk factors, because it describes outcomes after a rare emergency rather than routine pregnancy care. The study suggests that aortic dissection can occur at different aortic root sizes depending on the underlying risk factor (notably hypertension in this dataset), and that the trimester at onset related to fetal outcomes. Because this was a single-center retrospective series of patients who already had dissection and were treated surgically, it cannot tell how often dissection happens in pregnancy overall or predict risk for an individual person. [6]

Across this group of patients with inherited connective tissue disorders (including Marfan syndrome), stent-based repair of the thoracic aorta (the chest portion of the aorta) showed relatively low rates of major complications around the time of surgery, but substantial aorta-related events during follow-up. The overall pattern suggests that while the procedure can be performed with acceptable short-term safety in selected people, ongoing aortic changes and the need for additional procedures were common. [7]

This registry study included 330 patients treated from 2014 to 2024 and reported perioperative death, spinal cord injury, and stroke each in 2.1% of patients. Additional procedures were reported in 10.9% during the perioperative period, and by 18 months the estimated reintervention rate was 30.8%, with aortic enlargement changes reported in 40.2% and dissection spread in 20.4%. [7]

Results differed by aortic condition and by connective tissue disorder. People treated for type B dissection had a longer hospital stay (6 vs 5 days) and higher perioperative death (3.4% vs 0.0%) than those treated for thoracic aortic aneurysm, and Marfan patients had lower perioperative death (1.4% vs 6.1%) and higher midterm survival at 18 months (91.0% vs 71.6%) than those with Loeys-Dietz syndrome or Ehlers-Danlos syndrome. [7]

For people with Marfan syndrome who are discussing different ways to treat disease of the thoracic aorta, this study adds real-world information about stent-based repair: short-term complications were not common, but aortic changes and repeat procedures occurred often during follow-up. This is most directly relevant when considering stent repair for a thoracic aortic aneurysm or a type B dissection, and it highlights uncertainty about how durable the repair is over time in connective tissue disorders. [7]

Across these two preclinical studies, researchers focused on ways to slow aortic enlargement by changing how the aortic wall senses and responds to its surrounding support tissue. One line of work mapped a specific signaling chain triggered by fibronectin buildup, while the other tested a widely used cholesterol drug for broader effects on blood vessels, showing mixed results across different arteries. [8] [9]

One mouse study found that extra fibronectin in Marfan aortas can switch on a chain of signals (through an alphaVbeta3 receptor, PI3K, PDK1, and ILK) that increased nitric oxide-related activity and reduced how well the aorta could contract. In Marfan mice, disrupting fibronectin assembly or blocking several steps in this pathway reduced aortic widening and improved aortic function, and human Marfan aorta samples showed higher fibronectin and related pathway signals as well. The same study also reported that one ILK blocker caused deaths in mice over days, raising safety concerns for that specific approach. [8]

A second mouse study tested long-term atorvastatin and found it slowed aortic root enlargement and lowered aortic stiffness in both female and male Marfan mice. However, effects differed in other arteries: carotid wall thickness returned to normal, but carotid stretch did not, and blood flow changes in a brain artery went in opposite directions for females versus males. The study also reported that blood pressure increased in treated Marfan mice toward the level seen in control mice. [9]

For patients and caregivers, this month's papers mainly add background on potential future drug targets rather than changing current care, because both studies were done in Marfan mouse models. They suggest there may be more than one workable strategy to influence aortic enlargement (targeting a specific fibronectin-related signaling pathway versus using a systemic drug with multiple vascular effects), but it is still uncertain which approaches would be effective and safe in people, and whether benefits would be similar across different arteries or across sexes. [8] [9]

Across this group of studies, a practical issue that stood out was that retinal detachment in younger patients can be linked to inherited conditions, including Marfan syndrome. The evidence here comes from small to moderate-sized single-center clinical studies, so some results remain uncertain and may not apply to all patients.

In a prospective study of 28 Chinese patients under age 30 with retinal detachment and suspected genetic causes, Stickler syndrome, familial exudative vitreoretinopathy, and Marfan syndrome were among the most common underlying conditions identified. Marfan syndrome accounted for 4 of 28 patients in this cohort. [10]

Genetic testing results were not always straightforward: 40% of the identified gene variants were classified as variants of uncertain significance, meaning it was unclear whether they caused disease. The study reported that about two-thirds of these uncertain cases could still be given a likely diagnosis by combining genetic information with clinical features and family history. [10]

For patients and caregivers, this research mainly helps explain why genetic testing for eye complications can sometimes return uncertain results, and why clinicians may use eye exam details and family history to make sense of them. It also suggests that inherited conditions, including Marfan syndrome, can be part of the evaluation when retinal detachment happens at younger ages. What remains uncertain is how well these findings apply outside this single center and outside the specific population studied, especially when genetic variants are hard to interpret.

This study looked at one surgical approach for children who need an artificial lens placed when the eye does not have enough natural support for standard placement, a situation that can occur with Marfan syndrome-related lens shifting. Overall, the report described stable lens positioning and better measured vision over follow-up, but the evidence is limited by the small number of patients. [11]

In 11 eyes from 7 children treated with the Yamane intrascleral intraocular lens (IOL) fixation technique and followed for about 1.8 years, the implanted lenses stayed centrally positioned in all eyes. Median best-corrected visual acuity improved from 0.70 to 0.40 logMAR. [11]

Two patients developed early inflammatory membranes after surgery, and these resolved; the authors reported no additional complications during follow-up. Because this was a retrospective series without a comparison group, it cannot show how this technique compares with other approaches in similar children. [11]

For families dealing with lens problems related to Marfan syndrome, this study is a piece of early clinical evidence about one way surgeons may secure an artificial lens when normal support structures are weak. The results are most relevant as near-term background information for discussions about surgical options, while the long-term durability and how outcomes compare with other techniques remain uncertain due to the small, single-center, retrospective design.

Across these papers, the message is that Marfan syndrome can affect both the spine area and the hip joint in ways that may not be obvious on routine exams. Evidence is limited, but one small imaging study pointed to possible early hip cartilage changes in a specific area, and a case report described improvement after a tailored spine-area surgery. [12] [13]

In a cross-sectional study of 14 people with Marfan syndrome and 14 matched controls, hip MRI mapping showed higher values in the anterior superior acetabular cartilage (the socket-side cartilage in the front-upper region) in the Marfan group. The authors interpreted this as lower proteoglycan content in that subregion, while other measures (including femoral cartilage and collagen-related measures) were similar between groups. [12]

A case report described a 22-year-old woman with Marfan syndrome who had multiple anterior sacral meningoceles (fluid-filled outpouchings near the lower spine) treated with a posterior sacral approach. After surgery, her leg pain went away, and a follow-up MRI at 4 months showed shrinkage of the large meningocele; she still had occasional numbness after long walks. Because this is one patient, it cannot show how often others would have the same outcome. [13]

For patients and caregivers, this set of studies mainly adds background about where musculoskeletal and spine-related issues may show up in Marfan syndrome and how they can be evaluated. The hip MRI work is early research in a small group and does not by itself establish how likely symptoms are or how changes progress over time. The surgery report suggests that, in rare situations involving sacral meningoceles, carefully chosen surgical approaches can be followed by symptom improvement, but the uncertainty is high because it describes only one person.

Across three single-patient case reports, the main pattern was that major surgery in Marfan syndrome can be followed by uncommon complications involving the brain and behavior, the heart muscle, or fragile blood vessels in the lungs. These reports do not show how often these events happen, but they document that they can occur and may be difficult to confirm with a single test. [14] [15] [16]

One 17-year-old developed an acute psychotic episode with catatonia about two months after chest (sternal) repair, and symptoms fully resolved by day 24 after treatment; he remained symptom-free off medication for about three years. The report also noted emotional stressors around surgery, including body image distress and social difficulties, as possible contributors. [14]

One 55-year-old developed isolated cardiac sarcoidosis after cardiovascular surgery, supported mainly by multiple heart imaging tests even though a heart biopsy did not confirm the diagnosis. After receiving a heart device to support rhythm and pumping, followed by steroid treatment, he stayed clinically stable and had no heart failure hospitalizations during follow-up, while one follow-up scan did not show clear change. [15]

During lung surgery (bullectomy) for spontaneous pneumothorax in a 17-year-old with FBN1-related Marfan syndrome, a small pulmonary artery branch ruptured near the staple line and required additional surgery to control bleeding. Tissue examination of the artery wall showed changes consistent with underlying vessel fragility, suggesting that perioperative pressure and airflow changes might help trigger injury in vulnerable vessels. [16]

For patients and caregivers, these reports mainly serve as background information that rare, unexpected issues can occur around the time of surgery in Marfan syndrome, and that symptoms may involve mental and behavioral changes, new heart muscle problems, or bleeding from fragile vessels. Because each paper describes only one person, it is not possible to estimate risk or predict who might be affected, and the experiences may not apply to most surgeries or most patients. They do, however, show the kinds of complications clinicians may consider when new symptoms appear after an operation, and they highlight that confirmation may rely on careful follow-up and multiple types of evaluation rather than a single definitive test. [14] [15] [16]